STIM1 and myopathy: The identification of mutations in the RYR1 gene in TAM patients is of interest, since RYR1 mutations may represent the genetic cause of myopathy in at least a fraction of the patients affected by TAM that do not carry mutations in STIM1, ORAI1, or CASQ1 and therefore represent a new diagnostic target for these patients.